Related Experiment Video
Updated: Dec 13, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Access to European Union Agencies: Usual Suspects or Balanced Interest Representation in Open and Closed
1Department of Political Science University of Antwerp Antwerp.
Abstract:
To facilitate stakeholder representation, European Union (EU) agencies use a range of procedures, including closed consultation or advisory committees and open or public consultations. For analysing what kind of stakeholders gain access to advisory committees, we compare these two particular procedures. Two theoretical perspectives guide this analysis. The first is a resource-based account, which emphasizes informational needs and leads to the expectation that not only regulated interests but also EU-level associations and European Commission expert group members will gain representation through closed consultations. The second is a norm-based perspective that stresses the importance for agencies to establish a credible reputation, leading them to balance interest representation. A systematic comparison of stakeholders represented in agency committee with those participating in open consultations demonstrates that regulated interests have no systematic advantage in gaining access to closed consultations. Instead, closed consultations may diversify interest representation and facilitate the involvement of non-business interests.
Related Concept Videos
Drug Control Governance: Regulatory Bodies and Their Impact
Global Regulatory Systems
Healthcare Agencies I
The Representativeness Heuristic
Healthcare Agencies II
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

